Advertisement

Surgical Ablative Lasers and Fractional Microablative Lasers (Far Infrared): Organ Tissue

  • Giovanni Cannarozzo
  • Steven Paul Nisticò
  • Keyvan Nouri
  • Mario Sannino
Chapter
  • 110 Downloads

Abstract

Pulsed or continuous surgical lasers may be used to achieve ablation with minimal thermal damage. The possible applications of surgical lasers range from resurfacing treatments to vaporization of numerous benign dermatological lesions. CO2 (10,600-nm) and Er:YAG (2940-nm) lasers emit in the far-infrared spectrum. Surgical laser was introduced in the past as a surgical tool capable of vaporizing tissue. Side effects may present as hypertrophic or atrophic scars or hypo- and hyperpigmentation, often reversible.

Notes

Acknowledgments

Special thanks to Dr. Luigi Bennardo, Dr. Ester Del Duca and Dr. Giuseppe Lodi for their precious contribution in editing and revising this chapter.

References

  1. 1.
    Campolmi P, Bonan P, Cannarozzo G. Laser e sorgenti luminose in dermatologia. Milano: Masson-Elsevier; 2003.Google Scholar
  2. 2.
    Chiricozzi A, Saraceno R, Nisticò S, Giunta A, Cannizzaro MV, Chimenti S. Complete resolution of erythrodermic psoriasis in a HIV and HCV patient unresponsive to anti-psoriatic treatments after Highly Active Anti-Retroviral Therapy (ritonavir, atenzanavir, emtricitabine, tenofovir). Dermatology. 2012;225(4):333–7.CrossRefGoogle Scholar
  3. 3.
    Specchio F, Saraceno R, Chimenti S, Nisticò S. Management of non-melanoma skin cancer in solid organ transplant recipients. Int J Immunopathol Pharmacol. 2014;27(1):21–4.  https://doi.org/10.1177/039463201402700104.CrossRefPubMedGoogle Scholar
  4. 4.
    Specchio IC, Chimenti S, Tamburi F, Nisticò S. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Int J Immunopath Pharmacol. 2014;27(1):1–4.  https://doi.org/10.1177/039463201402700101.CrossRefGoogle Scholar
  5. 5.
    Bottoni U, Tiriolo R, Pullano S, Dastoli S, Amoruso G, Nistico S, Fiorillo A. Infrared saliva analysis of psoriatic and diabetic patients: similarities in protein components. IEEE Trans Biomed Eng. 2016;63(2):379–84.  https://doi.org/10.1109/TBME.2015.2458967.CrossRefPubMedGoogle Scholar
  6. 6.
    Chiricozzi A, Pitocco R, Saraceno R, Giunta A, Nisticò S, Chimenti S. New topical treatments for psoriasis. Exp Op Pharmacother. 2014;15(4):461–70.CrossRefGoogle Scholar
  7. 7.
    Terrinoni A, Codispoti A, Serra V, Bruno E, Didona B, Paradisi M, Nisticò S, Campione E, Napolitano B, Diluvio L, Melino G. Connexin 26 (GJB2) mutations as a cause of the KID syndrome with hearing loss. Biochem Biophys Res Commun. 2010;395(1):25–30.  https://doi.org/10.1016/j.bbrc.2010.03.098.CrossRefPubMedGoogle Scholar
  8. 8.
    Paolillo N, Piccirilli S, Giardina E, Rispoli V, Colica C, Nisticò S. Effects of paraquat and capsaicin on the expression of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes. Int J Immunopathol Pharmacol. 2011;24(4):861–8.  https://doi.org/10.1177/039463201102400405.CrossRefPubMedGoogle Scholar
  9. 9.
    Mercuri SR, Brianti P, Dattola A, Bennardo L, Silvestri M, Schipani G, Nisticò SP. CO2 laser and photodynamic therapy: study of efficacy in periocular BCC. Dermatol Ther. 2018;31(4):e12616.  https://doi.org/10.1111/dth.12616.CrossRefPubMedGoogle Scholar
  10. 10.
    Krupashankar DS, IADVL Dermatosurgery Task Force. Standard guidelines of care: CO2 laser for removal of benign skin lesions and resurfacing. Indian J Dermatol Venereol Leprol. 2008;74(Suppl):S61–7.PubMedGoogle Scholar
  11. 11.
    Krupashankar DS, Chakravarthi M, Shilpakar R. Carbon dioxide laser guidelines. J Cutan Aesthet Surg. 2009;2:72–80.  https://doi.org/10.4103/0974-2077.58519.SCrossRefGoogle Scholar
  12. 12.
    Rahman Z, MacFalls H, Jiang K, et al. Fractional deep dermal ablation induces tissue tightening. Lasers Surg Med. 2009;41:78–86.  https://doi.org/10.1002/lsm.20715.CrossRefPubMedGoogle Scholar
  13. 13.
    Prignano F, Campolmi P, Bonan P, Ricceri F, Cannarozzo G, et al. Fractional CO2 laser: a novel therapeutic device upon photobiomodulation of tissue remodeling and cytokine pathway of tissue repair. Dermatol Ther. 2009;22(Suppl 1):S8–15.  https://doi.org/10.1111/j.1529-8019.2009.01265.x.CrossRefPubMedGoogle Scholar
  14. 14.
    Gotkin RH, Sarnoff DS, Cannarozzo G, et al. Ablative skin resurfacing with a novel microablative CO2 laser. J Drugs Dermatol. 2009;8:138–44.PubMedGoogle Scholar
  15. 15.
    Campolmi P, Bonan P, Cannarozzo G, et al. Highlights of thirty-year experience of CO2 laser use at the Florence (Italy) Department of Dermatology. Sci World J. 2012;2012:546528.CrossRefGoogle Scholar
  16. 16.
    Filippini M, Del Duca E, Negosanti F, Bonciani D, Negosanti L, Sannino M, Cannarozzo G, Nisticò S. Fractional CO2 laser: from skin rejuvenation to vulvo-vaginal reshaping. Photomed Laser Surg. 2017;35(3):171–5.  https://doi.org/10.1089/pho.2016.4173. ISSN: 1549-5418, GS24 SC17 WOS13 IF1.62.CrossRefPubMedGoogle Scholar
  17. 17.
    Campolmi P, Bonan P, Cannarozzo G, Bruscino N, Moretti S. Efficacy and safety evaluation of an innovative CO2 laser/radiofrequency device in dermatology. J Eur Acad Dermatol Venereol. 2013;27(12):1481–90.  https://doi.org/10.1111/jdv.12029.CrossRefPubMedGoogle Scholar
  18. 18.
    Prignano F, Campolmi P, Cannarozzo G, et al. A study of fractional CO2 laser resurfacing: the best fluences through a clinical, histological, and ultrastructural evaluation. J Cosmet Dermatol. 2011;10(3):210–6. PMID: 21896133CrossRefGoogle Scholar
  19. 19.
    Chimento SM, Newland M, Ricotti C, Nistico S, Romanelli P. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo. J Drugs Dermatol. 2008;7(3):258–63. PMID: 18380207PubMedGoogle Scholar
  20. 20.
    Nisticò S, Saraceno R, Capriotti E, De Felice C, Chimenti S. Efficacy of monochromatic excimer light (308nm) for the treatment of atopic dermatitis in adults and children. Photomed Laser Surg. 2008;26(1):14–8.  https://doi.org/10.1089/pho.2017.2116.CrossRefPubMedGoogle Scholar
  21. 21.
    Nistico S, Tamburi F, Bennardo L, Dastoli S, Schipani G, Caro G, Fortuna MC, Rossi A. Treatment of telogen effluvium using a dietary supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera: results of an observational study. Dermatol Ther. 2019;32(3):e12842.  https://doi.org/10.1111/dth.12842.CrossRefPubMedGoogle Scholar
  22. 22.
    Muscoli C, Lauro F, Dagostino C, Ilari S, Giancotti LA, Gliozzi M, Costa N, Carresi C, Musolino V, Casale F, Ventrice D, Oliverio E, Palma E, Nisticò S, Procopio A, Mollace V. Olea Europea-derived phenolic products attenuate antinociceptive morphine tolerance: an innovative strategic approach to treat cancer pain. J Biol Reg Homeost Ag. 2014;28(1):105–16.Google Scholar
  23. 23.
    Cannarozzo G, Sannino M, Tamburi F, et al. Deep pulse fractional CO2 laser combined with a radio-frequency system: results of a case series. Photomed Laser Surg. 2014;32:7.  https://doi.org/10.1089/pho.2014.3733.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Giovanni Cannarozzo
    • 1
  • Steven Paul Nisticò
    • 2
  • Keyvan Nouri
    • 3
  • Mario Sannino
    • 1
  1. 1.Department of DermatologyUniversity of Rome Tor VergataRomeItaly
  2. 2.Department of Health ScienceMagna Graecia UniversityCatanzaroItaly
  3. 3.Department of Dermatology and Cutaneous SurgeryUniversity of Miami Leonard M. Miller School of MedicineMiamiUSA

Personalised recommendations